InnovAge Holding Third Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

InnovAge Holding (NASDAQ:INNV) Third Quarter 2025 Results

Key Financial Results

• Revenue: US$218.1m (up 13% from 3Q 2024).
• Net loss: US$11.4m (loss widened by 93% from 3Q 2024).
• US$0.084 loss per share (further deteriorated from US$0.043 loss in 3Q 2024).

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

All figures shown in the chart above are for the trailing 12 month (TTM) period

InnovAge Holding Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 1.9%. Earnings per share (EPS) missed analyst estimates.

Looking ahead, revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 7.0% growth forecast for the Healthcare industry in the US.

Performance of the American Healthcare industry.

The company's shares are up 4.2% from a week ago.

Balance Sheet Analysis

While earnings are important, another area to consider is the balance sheet. We have a graphic representation of InnovAge Holding's balance sheet and an in-depth analysis of the company's financial position.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.